Suchergebnisse - "Zang, Xingxing"

PubPharm (198)

41

Correction to: The TRIM protein Mitsugumin 53 enhances survival and therapeutic efficacy of stem cells in murine traumatic brain injury

enthalten in: Stem cell research & therapy | 2021

von Guan, F. | Huang, T. | Wang, X. | +15

42

ANTAGONIST ANTIBODIES AGAINST HUMAN IMMUNE CHECKPOINT CEACAM1 (CD66A) AND FORMULATIONS, KITS, AND METHODS OF USE THEREOF

enthalten in: Europäisches Patentamt | 2021

von ZANG XINGXING

43

Tissue-resident macrophages promote early dissemination of multiple myeloma via IL-6 and TNFα

enthalten in: Blood advances | 2021

von Akhmetzyanova, I. | Aaron, T. | Galbo, P. | +7

44

MONOCLONAL ANTIBODIES AGAINST IgV DOMAIN OF B7-H3 AND USES THEREOF

enthalten in: Europäisches Patentamt | 2021

von ZANG XINGXING

45

Reovirus sensitizes microsatellite stable colorectal cancer to anti-PD-1 treatment via cross-talk in innate and adaptive immune systems

enthalten in: bioRxiv.org | 2021

von Augustine, T. | John, P. | Friedman, T. | +9

46

MONOCLONAL ANTIBODIES AGAINST IgV DOMAIN OF B7-H3 AND USES THEREOF

enthalten in: Europäisches Patentamt | 2021

von ZANG XINGXING

47

B7 score and T cell infiltration stratify immune status in prostate cancer

enthalten in: Journal for immunotherapy of cancer | 2021

von Zhou, Q. | Li, K. | Lai, Y. | +10

48

KIR3DL3-HHLA2 is a human immunosuppressive pathway and a therapeutic target

enthalten in: Science immunology | 2021

von Wei, Y. | Ren, X. | Galbo, P. | +13

49

MONOCLONAL ANTIBODIES AGAINST HUMAN TIM-3

enthalten in: Europäisches Patentamt | 2021

von ZANG XINGXING

50

CHIMERIC ANTIGEN RECEPTORS TARGETING B7-H3 (CD276) AND ASSOCIATED METHODS

enthalten in: Europäisches Patentamt | 2021

von ZANG XINGXING